✦ LIBER ✦
A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies
✍ Scribed by Evan J. Wuthrick; Mitchell Kamrava; Walter J. Curran Jr; Maria Werner-Wasik; Kevin A. Camphausen; Terry Hyslop; Rita Axelrod; David W. Andrews; Jon Glass; Mitchell Machtay; Adam P. Dicker
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 226 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.